Diagnosis and management of bronchiolitis
- PMID: 17015575
- DOI: 10.1542/peds.2006-2223
Diagnosis and management of bronchiolitis
Abstract
Bronchiolitis is a disorder most commonly caused in infants by viral lower respiratory tract infection. It is the most common lower respiratory infection in this age group. It is characterized by acute inflammation, edema, and necrosis of epithelial cells lining small airways, increased mucus production, and bronchospasm. The American Academy of Pediatrics convened a committee composed of primary care physicians and specialists in the fields of pulmonology, infectious disease, emergency medicine, epidemiology, and medical informatics. The committee partnered with the Agency for Healthcare Research and Quality and the RTI International-University of North Carolina Evidence-Based Practice Center to develop a comprehensive review of the evidence-based literature related to the diagnosis, management, and prevention of bronchiolitis. The resulting evidence report and other sources of data were used to formulate clinical practice guideline recommendations. This guideline addresses the diagnosis of bronchiolitis as well as various therapeutic interventions including bronchodilators, corticosteroids, antiviral and antibacterial agents, hydration, chest physiotherapy, and oxygen. Recommendations are made for prevention of respiratory syncytial virus infection with palivizumab and the control of nosocomial spread of infection. Decisions were made on the basis of a systematic grading of the quality of evidence and strength of recommendation. The clinical practice guideline underwent comprehensive peer review before it was approved by the American Academy of Pediatrics. This clinical practice guideline is not intended as a sole source of guidance in the management of children with bronchiolitis. Rather, it is intended to assist clinicians in decision-making. It is not intended to replace clinical judgment or establish a protocol for the care of all children with this condition. These recommendations may not provide the only appropriate approach to the management of children with bronchiolitis.
Comment in
-
Oxygen therapy for bronchiolitis.Pediatrics. 2007 Mar;119(3):611. doi: 10.1542/peds.2006-3002. Pediatrics. 2007. PMID: 17332214 No abstract available.
-
High-dose systemic corticosteroids may be effective early in the course of bronchiolitis.Pediatrics. 2007 Apr;119(4):864-5; discussion 865-6. doi: 10.1542/peds.2006-2888. Pediatrics. 2007. PMID: 17403865 Clinical Trial. No abstract available.
-
The importance of disclaimers: distinction between optimal care and standard of care.Pediatrics. 2007 Aug;120(2):453-5; author reply 455. doi: 10.1542/peds.2007-0951. Pediatrics. 2007. PMID: 17671079 No abstract available.
-
Health care epidemiology perspective on the October 2006 recommendations of the Subcommittee on Diagnosis and Management of Bronchiolitis.Pediatrics. 2007 Oct;120(4):890-2. doi: 10.1542/peds.2007-1305. Pediatrics. 2007. PMID: 17908774 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical